Natco Pharma invests $8-M in US based organ transplant co. eGenesis

Publicly-listed, Hyderabad-headquartered Natco Pharma has invested USD 8 million in Massachusetts (USA)-headquartered eGenesis Inc ., a biotechnology company that focuses on developing safe and effective human compatible organs for transplant.This investment aims to support eGenesis' work in kidney, liver, and heart transplants, potentially addressing the global transplant shortage.